Offer - Urjas Oil for just ₹ 1
Methastar 0.2 mg Injection is a prescription medicine that is available as a Injection. It is primarily used for the treatment of Post Delivery Bleeding.
The optimal dosage of Methastar 0.2 mg Injection is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
The most common side effects of Methastar 0.2 mg Injection are Headache, Abdominal Pain, Hypertension. Some other side effects of Methastar 0.2 mg Injection have been listed ahead. Such side effects of Methastar 0.2 mg Injection normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Methastar 0.2 mg Injection has a Unknown effect for pregnant women and Unknown effect on lactating mothers. It is important to know if Methastar 0.2 mg Injection has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Methastar 0.2 mg Injection related warnings section.
Methastar 0.2 mg Injection can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Methastar 0.2 mg Injection in conditions like High Blood Pressure. The section on Methastar 0.2 mg Injection contraindications lists all such conditions.
Additionally, Methastar 0.2 mg Injection may also adversely react with other medicines. Refer to the list below for further details.
In addition to the above precautions for Methastar 0.2 mg Injection, it is important to know that it is safe while driving, and is habit-forming.
Methastar 0.2 mg Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult(Female) |
|
Is the use of Methastar 0.2 mg Injection safe for pregnant women?
It is not known what effect Methastar will have on pregnant women, because no research work has been carried out on this till date.
Is the use of Methastar 0.2 mg Injection safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Methastar for breastfeeding women are not known.
What is the effect of Methastar 0.2 mg Injection on the Kidneys?
Methastar rarely harms the kidneys.
What is the effect of Methastar 0.2 mg Injection on the Liver?
The liver can be affected by Methastar. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Methastar only after medical advice.
What is the effect of Methastar 0.2 mg Injection on the Heart?
Methastar may have severe effects on your heart, so do not take it without first consulting your doctor.
If you are suffering from any of the following diseases, you should not take Methastar 0.2 mg Injection unless your doctor advises you to do so -
Is this Methastar 0.2 mg Injection habit forming or addictive?
No, you will not get addicted to Methastar 0.2 mg Injection.
Is it safe to drive or operate heavy machinery when consuming?
Methastar 0.2 mg Injection will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, but consume Methastar 0.2 mg Injection only on doctor's advice.
Is it able to treat mental disorders?
No, Methastar 0.2 mg Injection cannot treat any kind of mental disorder.
Interaction between Food and Methastar 0.2 mg Injection
There isn't any research available on the side effects of taking Methastar 0.2 mg Injection with food.
Interaction between Alcohol and Methastar 0.2 mg Injection
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Methastar 0.2 mg Injection.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Methergine® (methylergonovine maleate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 331-332
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 837-839
